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Abstract: In this work, a steroidal gelator containing an imine bond was synthesized, and its 
gelation behavior as well as a sensitivity of its gels towards acids was investigated. It was 
shown that the gels were acid-responsive, and that the gelator molecules could be prepared 
either by a conventional synthesis or directly in situ during the gel forming process. The gels 
prepared by both methods were studied and it was found that they had very similar macro- 
and microscopic properties. Furthermore, the possibility to use the gels as carriers for 
aromatic drugs such as 5-chloro-8-hydroxyquinoline, pyrazinecarboxamide, and antipyrine 
was investigated and the prepared two-component gels were studied with regard to their 
potential applications in drug delivery, particularly in a pH-controlled drug release. 
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1. Introduction 
Steroids, as compounds with a wide array of different tasks in Nature, come in many varieties. But all 
of them combine a large and rigid framework with functional groups making them especially valuable as 
starting materials for organic synthesis. In this article we want to show the application of steroids in 
supramolecular gels. Supramolecular gels [1–6] are smart functional nanoscale materials with high 
potential for a wide range of advanced applications, among others [7–11], in drug delivery [12–14], tissue 
engineering [12], light-harvesting systems [7,9,15], and optoelectronics [10,11]. Their formation stems 
from spontaneous but controlled self-assembly of small molecules, often called low-molecular-weight 
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gelators (LMWGs), into a three-dimensional network with solvent molecules entrapped in its  
cavities [5,16]. Despite their mostly liquid composition, these systems demonstrate the appearance and 
rheological behaviour of solids. Besides steroids [17–20] other examples of supramolecular gels, based on 
natural building blocks like nucleobases [21–23], amino acids, or oligopeptides [24–28], have been reported. 
In recent years supramolecular gels have received increased attention as alternative materials to 
conventional polymer gels, mostly due to the possibility to install desired properties into a gelator 
structure, i.e., on a molecular level [7]. By a proper design of LMWGs, the self-assembly of the molecules 
can be arranged and controlled. Appropriately designed gelators, i.e., decorated with suitable functional 
groups, can be programmed for example to be responsive to external stimuli such as light, mechanical 
stress, pH, ionic strength, metal ions, or anions [29–34]. In most cases, a change on a molecular level results 
directly in a change of macroscopic properties of the whole system. Recently, several stimuli-responsive 
steroidal supramolecular gels exhibiting the before mentioned properties were reported, among others [17], 
pH and acid-responsive sterol-amino acid conjugates [35,36] and bile acid derivatives [37]. 
In a conventional gel preparation, gelators are synthesized beforehand and then dissolved in suitable 
solvents. However, in some cases gelators can be synthesized by mixing two or more components 
directly in a gelling solvent, where new covalent bonds between the building blocks are formed. This 
modern approach is called in situ gelation and recently some gelators of this type were reported [38–40]. 
It was shown that in comparison to the classic method, the in situ gelation often: (i) omits heating of the 
sample; (ii) occurs at ambient temperature; (iii) requires shorter gelation time; or (iv) takes place also in 
solvents which are not gelled by the conventional gelation [39]. Moreover, the components are needed in 
a certain ratio to achieve an effective gelator formation, therefore, a lack or excess of one of the 
components can be used as a tool to control the gelation process. 
In this work we present a synthesis of cholesteryl gelator containing an imine bond. Cholesterol and 
its derivatives are commonly used in the preparation of LMWGs due to the hydrophobic character of the 
cholesteryl unit and its strong tendency to self-aggregate. Many cholesterol-based gelators have been 
reported [17–19] and they have been often classified as ALS, A(LS)2, LS, and LS2 types according to the 
numbers of aromatic (A) and steroidal (S) units, and linkers (L) [18]. 
2. Results and Discussion 
2.1. Preparation and Gelation Behaviour of Imine 3 
The cholesteryl moiety 1 and 2-pyridinecarboxaldehyde (2) were used to prepare gelator 3 of an ALS 
type (Scheme 1). In our design p-phenylenediamine was chosen as a linker in order to synthesize stable 
(conjugated) imine 3, and to introduce an amide moiety (i.e., an acceptor and donor for intermolecular 
H-bonds) to the structure. The imine bond was embedded into the gelator structure due to: (i) its known 
sensitivity towards acids which we wanted to exploit as an acid-sensitive system; and (ii) its relatively 
rapid and easy formation at mild conditions, which allows an in situ gelator formation. To test these 
hypotheses, a formation and an acid catalysed hydrolysis of imine 3 were carried out and monitored by 
NMR. The reaction of amine 1 with the aldehyde 2 occurred at room temperature and it was completed 
within few hours providing time-stable imine 3 (ESI, Figure S1). However, when the imine 3 was treated 
with a catalytic amount of p-toluenesulphonic acid, it decomposed into its two precursors (protonated 
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compound 1, and compound 2) within several minutes (the majority of 3 decomposed within 45 min, see 
ESI, Figure S2 for details), confirming that the cleavage of the imine linkage under acidic conditions is 
facile and effective. 
Scheme 1. Design and synthesis of imine 3—gelator of an ALS type [18]. 
 
The gelation behaviour of individual compounds was studied in 16 different organic solvents and in 
water. The tests were carried out for both moieties separately (i.e., for 1, and for 2), and for the 
synthetically and the in situ prepared imine 3 (Table 1). Expectably, 2-pyridinecarboxyaldehyde (2) did 
not gelate any of the tested solvents at the concentration of 2% w/v, and amine 1 formed gels only in 
cyclohexane and DMSO. However, after mixing these two components together and the heating/cooling 
cycle, gel formation was observed in DMF and DMSO, and in higher alcohols starting from propan-1-ol. 
The same results were obtained when the gelation behaviour of a synthetically prepared imine 3 was 
tested. The corresponding imine gels (formed by synthetically and in situ prepared gelators) exhibited 
the same visual properties and the morphology of their xerogels, studied by SEM, was also very similar. 
The SEM micrograph did not reveal any regular fibrous structures. It only showed three-dimensional 
structures constructed from thin microflakes of different sizes and mostly rounded shapes (Figure 1, and 
ESI, Figure S11) suggesting that the gel microstructure was very fragile and collapsed upon solvent 
evaporation. We also tested the effect of the component ratio on the in situ gelation (ESI, Tables S2 and 
S3). As expected, we found that the effective gelation was reached when a 1:1 molar ratio of the 
components was used. An excess of 2-pyridinecarboxaldehyde did not significantly affect the gelation 
process, whereas the excess of amine 1 resulted in a sample precipitation (ESI, Table S2). We also 
investigated a possibility to prepare gel in situ omitting the heating/cooling cycle, which was recently 
reported [39]. Unfortunately, we did not observe an effective gelation at room temperature, not even 
after 24 h or ultrasonic treatment, suggesting that the reaction does not quantitatively occur in alcohols at 
room temperature and energy needs to be added to the reaction via heating. 
Table 1. Gelation tests (2% w/v). 
Solvents 1 2 3 (“in situ”) 3 Solvents 1 2 3 (“in situ”) 3 
toluene S S P P hexan-1-ol S S pG pG 
CH2Cl2 S S P P heptan-1-ol S S pG pG 
CHCl3 S S S S octan-1-ol S S pG pG 
CCl4 S S P P water I S - I 
methanol P S I I DMF S S pG pG 
ethanol P S I I DMSO G S G G 
propan-1-ol S S G G cyclohexane G I - I 
butan-1-ol S S G G hexane I I - I 
pentan-1-ol S S G G      
Note: S = soluble, P = precipitate upon cooling, G = gel, pG = partial gel, I = insoluble at the solvent boiling point. 
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Figure 1. SEM micrographs of xerogels from propan-1-ol of (a) of the in situ prepared imine 3; 
and (b) the synthetically prepared imine 3. 
 
In order to discover the non-covalent interactions involved in the gelation process, we carried out 
variable-temperature 
1
H-NMR measurements of the imine 3 gel in DMSO-d6 (Figure 2, and ESI, Figures 
S4 and S5). By heating the sample in 10 °C steps (30–120 °C), the broad signals gradually turned 
sharper. The well-resolved spectral patterns were finally observed at 100 °C, suggesting that the gel fully 
transformed to the solution state. As a control experiment, a 
1
H-NMR spectrum of imine 3 in a 
non-gelling concentration (0.2% w/v) was recorded (Figure 2). Chemical shifts of proton signals of 
imine 3 at the non-gelling concentration match those in the gel state at 30 °C indicating that the observed 
peaks correspond to the free molecules which are not tightly integrated in the gel network. With an 
increase of temperature, the chemical shifts of the signals did not change remarkably with the sole 
exception of the amide proton. The chemical shift values of N-H changed from 9.71 ppm at 30 °C to  
9.13 ppm at 120 °C. This indicates an increase in the strength of the N-H bond, direct evidence of the 
disentanglement of NH from a bonding state. This disruption of intermolecular hydrogen-bonding can 
be also indirectly observed by a small deshielding of signals of the protons of the phenyl ring (the 
strongest change is from 7.33 at 30 °C to 7.27 ppm at 120 °C).The experiment did not prove the presence 
of π-π stacking between pyridine units in the DMSO-gel, because only small shielding (0.01–0.05 ppm) 
of pyridine protons was observed. The spectra also showed that the increase of temperature in the 
presence of water (from the deuterated solvent) caused partial hydrolysis of imine 3 to the starting 
components 1 and 2. 
The presence of intermolecular hydrogen bonds was further confirmed by a dilution NMR 
experiment. The 
1
H-NMR spectra were recorded for the imine 3 at different concentration and showed 
deshielding of the NH signal at higher concentrations indicating the intermolecular hydrogen bond 
formation (ESI, Figure S3). Overall, we propose that the gel formation is caused by an aggregation of 
cholesteryl units via hydrophobic and van der Waals interactions in polar solvents, and that the structure 
is further stabilized by intermolecular hydrogen bonds between amide groups and possibly by π-π 
interactions between the aromatic parts of the molecules. 
  





H-NMR subspectra of imine 3 in DMSO-d6 at non-gelling concentration  
(0.2% w/v), and as a DMSO-d6 gel (2.5% w/v) at different temperatures (30–120 °C) with a 
highlighted shift of the amide proton signal (dotted arrow). 
 
2.2. Acid-Responsive Gels 
Considering the difference in the gelation behaviour of amine 1 and imine 3, and after successful acid 
catalysed hydrolysis of imine 3 monitored by NMR (ESI, Figure S2), we expected that the addition of a 
small amount of acid to the gel of imine 3 should result in a gel-sol transition. When we placed a 
catalytic amount of p-toluenesulphonic acid on the top of a gel of imine 3 in propan-1-ol, butan-1-ol, 
pentan-1-ol, and DMSO, a gel-sol transition occurred (Scheme 2, and ESI, Figure S10). We suppose that 
the hydrolysis of the imine linkage weakened the intermolecular interactions, resulting in the 
dissociation of the self-assembled network of the gelators and giving rise to an acid-mediated gel-sol 
transition. This process occurred within less than 2 h, and could be speeded up to several minutes under 
an ultrasonic treatment. In another experiment, a drop of hydrochloric acid (1 M aqueous solution) was 
added resulting in a gel-sol transition within several minutes (approx. 15 min). And again, the process 
could be speeded up to few minutes by an ultrasonic treatment. These results, together with a recently 
published report [41], show that the organogels formed by imines are acid-responsive. We believe that 
such systems could find potential applications in drug release systems and therefore, gels based on imine 
3 were further studied. 
2.3. Two Component Gel System 
In order to study the potential of gelator 3 in drug delivery [12–14], two component gels [42,43] 
containing different drugs were prepared. As a second component, aromatic drugs of different polarities 
were chosen: 5-chloro-8-hydroxyquinoline (cloxyquine, Q), pyrazinecarboxamide (pyrazinamide, PC), 
and antipyrine (phenazone, AP) (Figure 3). The quinoline derivative and pyrazinecarboxamide are drugs 
used in the treatment of tuberculosis [44,45], and antipyrine is analgesic and antipyretic. These 
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pharmaceuticals were chosen because of their aromatic character (i.e., possibility to intercalate to the 
aromatic parts of imine 3), commercial availability, low price, and gelation potential (recently, 
5-chloro-8-hydroxyquinoline was found to be an effective gelator for alcohol-water mixtures [46]). 
Scheme 2. In situ gelation and acid-induced gel-sol transition of 3 in propan-1-ol. 
 
Figure 3. Chemical structures of the chosen drugs: 5-chloro-8-hydroxyquinoline (Q), 
pyrazinecarboxamide (PC), and antipyrine (AP). 
 
It was found that the mixtures of imine 3 and the drugs in a 1:1 ratio formed gels in most of the 
selected solvents (Table 2). In order to investigate interactions between the gelator and drug molecules, 
1
H-NMR spectra of imine-drug gels (Figure 4) and variable temperature 
1
H-NMR spectra of a gel of 
imine 3 and pyrazinecarboxamide were recorded (ESI, Figures S6 and S7). The drug signals in the 
spectra are not sharp suggesting that the mobility of the drug molecules is restricted within the gel 
network. As it was proposed by Miravet et al. [47], broadening of the signals, indicating shorter T2 
relaxation times, is often caused by a fast exchange between molecules in liquid-like (―visible‖ by 
NMR) and solid-like (―invisible‖ by NMR) phases, which means in our case between the free dissolved 
drug molecules and the drug molecules interfering in the gelator network. With an increase of 
temperature the gel melts and the drug is fully released to the solution and as a consequence, the signals 
become sharper. The fully sharp signals were observed at 100 °C (see Figures S6 and S7) which 
corresponds to the gel-sol transition of the gel of imine 3 (Figure 1). Unfortunately, the experiment did 
not prove the presence of π-π stacking either between drug molecules or between drug and gelator 
molecules in a DMSO-gel, because additional shifts, besides the small upfield shifts (approximately  
0.05 ppm) of the aromatic proton signals expected for an increase of temperature, are missing. 
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Table 2. Gelation tests (2% w/v). 
Solvents 3 Q 3 + Q PC 3 + PC AP 3 + AP 
ethanol I R  P I S I 
propan-1-ol G G G P G S G 
butan-1-ol G R G P G S G 
pentan-1-ol G R pG P G S G 
hexan-1-ol pG R pG P G S G 
octan-1-ol pG R pG P pG S pG 
DMF pG S pG S pG S pG 
DMSO G S G S G S G 
Note: S = soluble, P = precipitate upon cooling, G = gel, pG = partial gel, R = recrystallization upon cooling,  
I = insoluble at the solvent boiling point. 
Figure 4. Comparision of the 
1
H-NMR spectra of the different imine-drug gels in DMSO-d6 (3% w/v). 
 
In order to investigate an influence of a drug on the molecular packing of the gelator, 
13
C cross 
polarization magic angle spinning (CPMAS) NMR spectra of xerogels of imine 3, and of imine 3 and 
pyrazinecarboxamide in a 1:1 ratio were recorded. As can be seen from Figure 5 (and Figure S8 in ESI), 
the spectra display very similar patterns suggesting that the presence of a drug does not significantly 
affect the packing mode of imine 3 in the xerogel state. Moreover, the spectra show that imine 3 is much 
more crystalline compared to the drug because the drug signals can be hardly seen in the spectrum. Some 
of the signals reveal a double resonance pattern indicating the samples being either (i) a mixture of 
different polymorphic forms, or (ii) composed of a form having two non-equivalent molecules present in 
an asymmetric unit. A similar observation has been reported earlier for bile acid-based gelators and it 
was shown to be due to the presence of two non-equivalent molecules in the crystal lattice [48]. 
The morphology of the xerogels of the imine-drug gels from pentan-1-ol and DMSO was studied by 
SEM (ESI, Figure S11). Micrographs of xerogels of imine 3 from alcohols and from DMSO displayed 
similar microstructures regardless of the presence or absence of the drugs suggesting that the drug 
molecules did not significantly affect the way of self-assembly of the gelator. Only images of the xerogel 
of 3+PC from pentan-1-ol showed a slightly different arrangement with partly integrated elongated 
crystals (ESI, Figure S11b). These crystals could represent drug molecules which were not too strongly 
incorporated to the gel network and could freely crystallize during the sample preparation when the 
solvent was slowly evaporated. 





C CPMAS NMR spectra of (a) xerogel of 3 from propan-1-ol; (b) xerogel of 3 
and PC (1:1) from propan-1-ol. 
 
2.4. Controlled Drug Release 
In order to examine the potential of the two component gels in drug delivery [12–14], the release of a 
drug from gel to water was studied. For this purpose, we chose a gel of imine 3 and pyrazinecarboxamide 
in pentan-1-ol. Pyrazinecarboxamide was selected as a model drug due to its suitable solubility in water 
(15 g/L at 25 °C). Gels in pentan-1-ol were chosen because of their stability and because pentan-1-ol 
forms a two layered system with water, which made the drug release experiments easy to monitor. Gel 
samples of imine 3 and pyrazinecarboxamide were treated with water either without or with 
p-toluenesulfonic acid. After 0.5, 1, 2, 4 and 24 h, the water layers were separated off and the amount of 
the released drug was analysed by NMR measurements. Control experiments, in which 
pyrazinecarboxamide was dissolved in pentan-1-ol and treated either with water (exp. A) or with acidic 
water (exp. B), were carried out as well. To check the drug release under non-calm conditions, the 
samples were treated by ultrasonic for 10 min and after one hour of standing without any additional 
disturbance, the water layers were checked (in the same way like in the other drug release experiments). 
The results are summarized in Figures 6 and 7 (for details see ESI, Figure S13 and Table S4). 
Due to the fact that water is more dense than the gel from pentan-1-ol, the water put above the gel 
sample diffused through the gel and thus lifted the gel layer to the top (within the first 2–4 h). Naturally, 
this water penetration through the gel washed out the major amount of the drug in the first several hours 
of the experiment as can be seen from Figure 6. 
Figure 6. Release of PC from the gel to the water layer under neutral and acidic conditions. 
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Figure 7. Percentage of PC released to the water layer after ultrasonic treatment. 
 
Furthermore, Figure 6 shows that the drug release from the gel samples was smaller compared to the 
control experiment A, but still occurred. This indicates that the drug is not strongly integrated to the gel 
network and can be washed out when water penetrates the gel as described above. Therefore, such 
system could find potential applications in a slow drug release, where a distribution in small quantities 
over longer time is needed. Contrarily, when the gel samples were treated with acidic water, the situation 
changed significantly. Under acidic conditions, a gel-sol transition occurred and as a consequence, the 
drug release to the water layer was much quicker compared to the situation when the gel was treated only 
with water. The results of the drug release from the gel under acidic conditions were comparable to those 
of the control experiment B indicating that the gel hydrolysis and subsequent drug release were efficient. 
This outcome supports the idea that acid-responsive gel systems with entrapped pharmaceuticals could 
be effectively used in drug delivery when pH-induced drug release is needed. 
3. Experimental 
3.1. General 
Analytical grade reagents and solvents were used for the synthesis, purification and gelation studies. 
Cholesteryl chloroformate was purchased from Alfa Aesar (Karlsruhe, Germany), and p-phenylenediamine 
and 2-pyridinecarboxaldehyde from Sigma Aldrich (Steinheim, Germany). 2-pyridinecarboxaldehyde 
was freshly distilled before use. Pharmaceuticals for the drug release experiments were purchased from 





C-NMR experiments were run with a Bruker Avance DRX 500 NMR 
spectrometer equipped with a direct observation BBO probe head working at 500.13 MHz for 
1
H and at 
125.76 MHz for 
13
C-NMR spectra were measured in CDCl3 and the chemical shifts were referenced to 
the solvent signal (δ = 7.26 ppm for 
1
H, and δ = 77.0 ppm for 
13
C). The numbering of the steroidal part is 
according to the IUPAC rules. Molecular masses were measured either by using a Micromass LCT 
ESI-TOF mass spectrometer or by a VG AutoSpace 3500 HR-MS high resolution mass spectrometer. IR 
spectra were recorded on a Bruker Tensor 27 FTIR spectrometer. 
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3.2. Preparation of Compound 1 
Compound 1 was prepared according a previously reported procedure [49]. The desired product was 
obtained as a light yellow solid in 34% yield. δH (500.13 MHz; CDCl3): 0.68 (3H, s, 18-CH3), 0.87 (6H, 
dd, J = 2.2; 6.6 Hz, 26-CH3 + 27-CH3), 0.92 (3H, d, J = 6.5 Hz, 21-CH3), 1.03 (3H, s, 19-CH3), 4.58 (1H, 
m, 3-CH), 5.39 (1H, m, 6-CH), 6.33 (1H, bs, NH), 6.64 (2H, benzene ring), 7.14 (2H, benzene ring). δC 
(125.7 MHz; CDCl3): 11.86 (C-18), 18.72 (C-21), 19.33 (C-19), 21.06 (C-11), 22.55 (C-27), 22.80 
(C-26), 23.84 (C-23), 24.29 (C-15), 28.00 (C-25), 28.14 (C-2), 28.22 (C-16), 31.90 (C-7), 31.91 (C-8), 
35.79 (C-20), 36.20 (C-22), 36.59 (C-10), 37.01 (C-1), 38.52 (C-4), 39.52 (C-24), 39.76 (C-12), 42.33 
(C-13), 50.04 (C-9), 56.17 (C-17), 56.71 (C-14), 74.66 (C-3), 115.62 (benzene ring), 121.00 (benzene 
ring), 122.61 (C-6), 129.46 (benzene ring), 139.74 (C-5), 142.59 (benzene ring), 153.58 (C=O); 
νmax/cm
−1
: 3407, 3332 (NH), 2936, 2866 (CH), 1728 (C=O, -O), 1631 (C=O, -NH), 1525 (NH, bending) 




, 100%), 1063.85 ([2M+Na]
+
, 27%); m/z (HR-ESI) 521.4101, 
[C34H52N2O2+H]
+
 requires 521.4102; 543.3933, [C34H52N2O2+Na]
+
 requires 543.3921. 
3.3. Preparation of Compound 3 
Compound 1 (200 mg, 0.384 mmol) was dissolved in dry CH2Cl2 (8 mL), then freshly destilled 
2-pyridinecarboxyaldehyde (2) was added (36.5 µL, 0.384 mmol). The mixture was stirred at rt under N2 
atmosphere for 18 h. After a solvent evaporation, product 3 was obtained as a light orange solid in a 
quantitative yield (233 mg). δH (500.13 MHz; CDCl3): 0.68 (3H, s, 18-CH3), 0.87 (6H, dd, J = 2.2; 6.6 Hz, 
26-CH3 + 27-CH3), 0.92 (3H, d, J = 6.5 Hz, 21-CH3), 1.03 (3H, s, 19-CH3), 4.62 (1H, m, 3-CH), 5.40 
(1H, m, 6-CH), 6.73 (1H, bs, NH), 7.30 (2H, benzene ring), 7.34 (1H, pyridine ring), 7.44 (2H, benzene 
ring), 7.79 (1H, pyridine ring), 8.18 (1H, pyridine ring), 8.62 (1H, s, imine-H), 8.70 (1H, pyridine ring). 
δC (125.7 MHz; CDCl3): 11.85 (C-18), 18.71 (C-21), 19.31 (C-19), 21.05 (C-11), 22.54 (C-27), 22.79 
(C-26), 23.84 (C-23), 24.27 (C-15), 27.99 (C-25), 28.09 (C-2), 28.21 (C-16), 31.87 (C-7), 31.90 (C-8), 
35.78 (C-20), 36.19 (C-19), 36.58 (C-10), 36.97 (C-1), 38.45 (C-4), 39.51 (C-24), 39.74 (C-12), 42.32 
(C-13), 50.02 (C-9), 56.16 (C-17), 56.69 (C-14), 75.08 (C-3), 119.27 (benzene ring), 121.74 (pyridine 
ring), 122.10 (benzene ring), 122.77 (C-6), 124.91 (pyridine ring), 136.58 (pyridine ring), 137.15 
(benzene ring), 139.57 (C-5), 145.97 (benzene ring), 149.66 (pyridine ring), 153.00 (C=O), 154.76 
(pyridine ring), 159.21 (C=N); νmax/cm
−1
: 3407, 3332 (NH), 2934, 2866 (CH), 1727 (C=O, -O), 1626 









, 25%); m/z (HR-ESI) 610.4363, [C40H55N3O2+H]
+
 requires 610.4367. 
3.4. Gelation Tests 
In a typical gelation test a weighed amount of the gelator was mixed with a measured volume of the 
selected solvent in a sealed 5 mL test tube. The sample was sonicated for ca. 2–3 min and then the 
mixture was heated until the solid was completely dissolved (if soluble). The resulting solution was 
allowed to slowly cool down to room temperature. Finally the test tubes were inverted to observe if the 
contents could still flow. Upon cooling down, the formation of gel (G), precipitate (P), or solution (S) 
was detected. 
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3.5. NMR Studies 
1
H-NMR spectra of imine 3 formation and hydrolysis, 
1
H-NMR spectra of imine-drug gels and 
1
H-NMR spectra for the drug release experiments were recorded with a Bruker Avance DPX 250 





H-NMR spectra of gels were recorded with a Bruker Avance DRX 500 NMR 
spectrometer equipped with a BBO probe head working at 500.13 MHz for 
1
H. The gel samples were 
prepared directly in an NMR tube; a weighed amount of a gelator, or a mixture of a gelator and drug, was 
dissolved upon heating in 0.6 mL of DMSO-d6, and the gel samples were stabilized overnight. The VT 
1
H-NMR experiments were conducted varying the temperature by 10 °C steps. The samples were allowed 
to stabilize for 5 min at each temperature before acquiring the spectra. 
13
C CPMAS NMR spectra were recorded with a Bruker AV 400 spectrometer equipped with a 4 mm 
standard bore CPMAS probe. The dried and finely powdered samples were packed in ZrO2 rotors. The 
experiments were carried out at a 10 kHz spinning rate under Hartman-Hahn condition at the contact 
time being 2 ms with 5 s recycle delay. The number of scans varied between 400–1,000. FIDs were zero 
filled twice and apodized by 20 Hz exponential window function prioir to Fourier transform (FT). The 
13
C chemical shift was calibrated using a carbonyl signal of a glycine sample at 176.03 ppm as an 
external standard. Complete lists of acquisition and processing parameters are available by E. K. on request. 
3.6. SEM Measurments 
Scanning electron micrographs of xerogels were taken on a Bruker Quantax400 EDS microscope 
equipped with a digital camera. The samples of the xerogels were prepared by placing a hot, clear 
solution of the gelator on carbon tape over a sample stub. The samples were dried at room temperature 
and then sputter coated with a thin layer of gold in a JEOL Fine Coat Ion Sputter JFC-1100. 
3.7. Drug Release Experiments 
The gels of imine 3 and pyrazinecarboxamide (2.8% w/v), prepared in a 1:1 ratio in 0.5 mL of 
pentan-1-ol (nPC = 0.0195 mmol), were stabilised overnight. Then water (0.5 mL) either without or with 
p-toluenesulfonic acid (0.0053 mmol) was added. The samples stayed without any shaking or other type 
of disturbance. Water layers (0.4 mL) were separated off at certain times (after 0.5, 1, 2, 4 and 24 h), and 
after solvent evaporation, they were dissolved in 0.6 mL of D2O and analysed by NMR with succinic 
acid (0.0042 mmol) as an internal standard. As control experiments (A and B), pyrazinecarboxamide 
(0.0195 mmol) was dissolved in pentan-1-ol (0.5 mL), and the samples were treated in the same way as 
the gel samples (adding of 0.5 mL of water either without or with 0.0053 mmol of p-toluenesulfonic 
acid, and then analysed by NMR with 0.0085 mmol of succinic acid as an internal standard). The 
percentage of the released drug was calculated from the peak area of drug signals of a sample to the peak 
area of drug signals of a reference sample which was prepared by dissolving pyrazinecarboxamide 
(0.0195 mmol) in 0.6 mL of D2O with succinic acid (0.0085 mmol) as an internal standard. 
  




In summary, imine 3 represents the first gelator which forms in situ acid-responsive supramolecular 
gels. The gelator can also be prepared synthetically beforehand. In both cases the resulting gels exhibit 
the same macroscopic and microscopic properties without any loss by the in situ generation of the gel. 
The modern in situ approach to gel formation is still very rare [38–40] but should soon see a tremendous 
increase in popularity considering the advantages already described for these systems [39]. Besides the 
shortened gel preparation time integral to all in situ formations, the system here described can be 
controlled by changes in the molar ratio of the components. Another speciality of the described gelator is 
the imide moiety designed into the structure not just to facilitate the in situ formation but also to afford 
an acid-induced hydrolysis. This acid sensitivity we were able to exploit as a drug release system for 
different aromatic drugs. The drugs were before embedded into the gel network. In contact with water 
these two-component gels are slowly releasing the drugs constituting a slow drug release system. 
Contrarily, by adding acid, the drugs can be instantly released from the gel network. We believe that 
acid-responsive gels containing imine bonds are promising soft materials with many potential 
applications in drug delivery and controlled release systems [12–14]. 
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